Surgical Metabolism and Nutrition : eISSN 2465-8383 / pISSN 2233-5765

Table. 1.

Table. 1.

Demographic data and clinical characteristics according to whether they were treated with chemotherapy

Total number of patients or average (N=374)Patients without chemotherapy (N=137)Patients with chemotherapy (N=237)P-value
Sex0.599
 Male231 (61.8%)87 (63.5%)144 (60.8%)
 Female143 (38.2%)50 (36.5%)93 (39.2%)
Age (mean±SD, years)63.8±11.265.6±11.662.8±10.80.021
Body mass index (mean±SD, kg/m2)23.4±3.323.7±3.223.2±3.40.253
ASA0.116
 1180 (48.1%)59 (43.1%)121 (51.0%)
 2183 (48.8%)71 (51.8%)112 (47.3%)
 311 (2.9%)7 (5.1%)4 (1.7%)
Instant nutrition assessment0.932
 Good244 (65.2%)89 (65.0%)155 (65.4%)
 Poor130 (34.8%)48 (35.0%)82 (34.6%)
Location of colorectal cancer0.195
 Right130 (34.8%)45 (32.8%)85 (35.9%)
 Left177 (47.3%)61 (44.5%)116 (48.9%)
 Rectum67 (17.9%)31 (22.7%)36 (15.2%)
Method of operation0.001
 Open104 (27.8%)24 (17.5%)80 (33.8%)
 Laparoscopy270 (72.2%)113 (82.5%)157 (66.2%)
TNM stage<0.001
 013 (3.5%)13 (9.5%)0 (0.0%)
 177 (20.6%)77 (56.2%)0 (0.0%)
 298 (26.2%)34 (24.8%)64 (27.0%)
 3135 (36.1%)11 (8.0%)124 (52.3%)
 451 (13.6%)2 (1.5%)49 (20.7%)
Complication0.303
 No328 (87.7%)117 (85.4%)211 (89.0%)
 Yes46 (12.3%)20 (14.6%)26 (11.0%)
Length of stay (mean±SD, days)10.1±3.99.6±3.610.3±4.20.086
CEA (ng/mL)13.2±46.63.7±4.218.7±57.6<0.001
 ≤5253 (67.6%)111 (81.0%)142 (59.9%)<0.001
 >5121 (32.4%)26 (19.0%)95 (40.1%)
Severe weight loss
 Postoperative 1 week76 (20.3%)21 (15.3%)55 (23.2%)0.068
 Postoperative 6 weeks138 (36.9%)42 (30.7%)96 (40.5%)0.057
 Postoperative 3 months87 (23.3%)23 (16.8%)64 (27.0%)0.024
 Postoperative 6 months32 (8.6%)8 (5.8%)24 (10.1%)0.153
Surg Metab Nutr 2019;10:46-53 https://doi.org/10.18858/smn.2019.10.2.46
© 2019 Surg Metab Nutr